Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sclerosis, Progressive Systemic”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Testing effectiveness (Phase 2)Study completedNCT03041025
What this trial is testing

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Looking for participantsNCT07473154
What this trial is testing

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Who this might be right for
Diffuse Cutaneous Systemic SclerosisRheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+1 more
Quell Therapeutics Limited 16
Testing effectiveness (Phase 2)Study completedNCT04137224
What this trial is testing

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring 27
Not applicableStudy completedNCT04411498
What this trial is testing

Effects of Fibromyalgia Syndrome in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisFibromyalgia
Antalya Training and Research Hospital 140
Testing effectiveness (Phase 2)Study completedNCT00442611
What this trial is testing

Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

Who this might be right for
Scleroderma, DiffuseScleroderma, Systemic
Stanford University 10
Post-approval studies (Phase 4)Study completedNCT04464434
What this trial is testing

Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic SclerosisSystemic Scleroses, DiffuseScleroderma+5 more
UMC Utrecht 60
Large-scale testing (Phase 3)UnknownNCT01586663
What this trial is testing

Serial Night Time Position Splint on Systemic Sclerosis

Who this might be right for
Diffuse Systemic Sclerosis
Federal University of São Paulo 76
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Early research (Phase 1)Study completedNCT00433186
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Boston University 30
Testing effectiveness (Phase 2)Ended earlyNCT01545427
What this trial is testing

Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma

Who this might be right for
Scleroderma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Not applicableStudy completedNCT02339441
What this trial is testing

Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Early Diffuse Cutaneous Systemic Sclerosis
University of Manchester 320
Testing effectiveness (Phase 2)Study completedNCT02503644
What this trial is testing

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, DiffuseDiffuse Cutaneous Systemic Sclerosis
Inventiva Pharma 145
Testing effectiveness (Phase 2)Study completedNCT01651143
What this trial is testing

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Not applicableUnknownNCT05168215
What this trial is testing

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.

Who this might be right for
SclerodermaDigital UlcerAutoimmune Diseases+2 more
Elpen Pharmaceutical Co. Inc. 300
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Not applicableStudy completedNCT04246528
What this trial is testing

SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)

Who this might be right for
SclerodermaSystemic Sclerosis
Lady Davis Institute 169
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Load More Results